Evidence map›Paper›PMID 37383074›Full record

ArticleNanoscale advances2023

Supramolecular Pd@methioine-EDTA-chitosan nanocomposite: an effective and recyclable bio-based and eco-friendly catalyst for the green Heck cross-coupling reaction under mild conditions.

Mohammad Dohendou, Mohammad G Dekamin, Danial Namaki

Abstract read
In one paragraph

Article in Nanoscale advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mohammad DohendouPharmaceutical and Heterocyclic Compounds Research Laboratory, Department of Chemistry, Iran University of Science and Technology Tehran 16846-13114 Iran mdekamin@iust.ac.ir.ORCID https://orcid.org/0000-0002-3627-0374
Mohammad G DekaminPharmaceutical and Heterocyclic Compounds Research Laboratory, Department of Chemistry, Iran University of Science and Technology Tehran 16846-13114 Iran mdekamin@iust.ac.ir.ORCID https://orcid.org/0000-0002-7018-7363
Danial NamakiPharmaceutical and Heterocyclic Compounds Research Laboratory, Department of Chemistry, Iran University of Science and Technology Tehran 16846-13114 Iran mdekamin@iust.ac.ir.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Supramolecular palladium(ii) supported on modified chitosan by dl-methionine using an ethylenediaminetetraacetic acid linker (Pd@MET-EDTA-CS) was designed and prepared through a simple procedure. The structure of this novel supramolecular nanocomposite was characterized by different spectroscopic, microscopic and analytical techniques including FTIR, EDX, XRD, FESEM, TGA, DRS, TEM, AA, and BET. The obtained bio-based nanomaterial was successfully investigated, as a highly efficient and green heterogeneous catalyst, in the Heck cross-coupling reaction (HCR) for the synthesis of various valuable biologically active cinnamic acid ester derivatives from the corresponding aryl halides using several acrylates. Indeed, aryl halides containing I or Br survived very well under optimized conditions to afford the corresponding products compared to the substrates with Cl. The prepared Pd@MET-EDTA-CS nanocatalyst promoted the HCR in high to excellent yields and short reaction times with minimum Pd loading (0.0027 mol%) on its structure as well as without any leaching occurring during the process. The recovery of the catalyst was performed by simple filtration and the catalytic activity remained approximately constant after five runs for the model reaction.

Identifiers

PMID37383074
PMCPMC10295217

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.